Example: Heart Attack
Search clinical trials for: 68Ga-FAPI-RGD
Total 2493 results
-
NCT00460096Completed
-
NCT07505199Not yet recruitingCell Therapy | Ischemic Cardiomyopathy
-
NCT07524322RecruitingCervical Cancer | Breast Cancer | Advanced Breast Cancer | Ovarian Cancer | Endometrial Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA Mutation | HER2- Negative Breast Cancer
-
NCT06715293RecruitingGastrointestinal Bleeding | Melena | Hematemesis
-
NCT05566899Recruiting
-
NCT03566043Active, not recruitingMucopolysaccharidosis Type II (MPS II)
-
NCT03999801Enrolling by invitationWet Macular Degeneration | Neovascular Age-related Macular Degeneration
-
NCT03066258CompletedNeovascular Age-related Macular Degeneration | Wet Age-related Macular Degeneration
-
NCT06444412RecruitingWHO Grade 3 Glioma | WHO Grade 4 Glioma
-
NCT05001204RecruitingGastrointestinal Stromal Tumors
-
NCT06091748CompletedAdvanced Gastroenteropancreatic Neuroendocrine Tumor
-
-
NCT05989997CompletedSolid Tumor | Positron-Emission Tomography(PET)
-
NCT03136328CompletedNeuroendocrine Tumors
-
NCT02441062CompletedNeuroendocrine Tumors | Medulloblastoma | Neuroblastoma | Carcinoid Tumors
-
NCT06560164RecruitingAnemia | Extracorporeal Membrane Oxygenation | Transfusion | ECMO | Red Blood Cell
-
NCT01711346CompletedFocus: Assess Post Infusion Viability of S303 RBCs
-
NCT06479811RecruitingNasopharyngeal Carcinoma | Olfactory Neuroblastoma | Esthesioneuroblastoma | Somatostatin Receptor Positive | Head and Neck Tumors | Small Cell Lung Cancers | Gastrointestinal Neuroendocrine Tumors | Pheochromocytoma/Paragangliomas | Kidney Cancers | Sinonasal Neuroendocrine Carcinoma
-
NCT06427798RecruitingPheochromocytoma | Somatostatin Receptor Positive | Paragangliomas | Gastrointestinal Neuroendocrine Tumors
-
NCT04484701Active, not recruitingProstatic Cancer | Prostatic Neoplasm
-
NCT06462183RecruitingAdenoid Cystic Carcinoma | Colorectal Cancer
-
-
NCT06516120CompletedStroke | Healthy Aging
-
NCT04571970CompletedMucopolysaccharidosis Type II (MPS II)
-
NCT04832724CompletedWet Macular Degeneration | Neovascular Age-related Macular Degeneration | Wet Age-related Macular Degeneration
-
NCT05832359CompletedChildhood Rheumatic Diseases
-
NCT00510575Completed
-
NCT01168882Withdrawn
-
NCT01398579UnknownIntestinal Metaplasia | Intestinal Dysplasia
-
NCT00449423TerminatedAcute Heart Failure
-
NCT05983198Active, not recruiting
-
NCT07385950Not yet recruitingSolid Tumors | Adult | PET / CT
-
-
NCT07006012RecruitingLymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
-
NCT06731218RecruitingDiabetes Mellitus | Diabetes Mellitus, Type 1
-
NCT05693142RecruitingDuchenne Muscular Dystrophy
-
NCT03580083SuspendedHurler Syndrome | Hurler-Scheie Syndrome | Mucopolysaccharidosis Type I (MPS I)
-
NCT06396286Active, not recruitingScoliosis | Adolescent Idiopathic Scoliosis | Spine Deformity
-
NCT07104513Active, not recruiting
-
NCT04408703CompletedUlcerative Colitis
-
NCT03322930CompletedRetinitis Pigmentosa | AMD
-
NCT02329548CompletedAnxiety | Syncope | Postural Tachycardia Syndrome
-
NCT04928820TerminatedBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8
-
NCT04279561TerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8
-
NCT06995976Recruiting
-
NCT06717113RecruitingMultiple Myeloma and Malignant Plasma Cell Neoplasms
-
NCT06256705RecruitingRadiotherapy | Gastroenteropancreatic Neuroendocrine Tumor
-
NCT01970228CompletedInfection of Total Hip Joint Prosthesis | Adverse Reactions to Metal Debris | Mechanical Loosening of Prosthetic Joint
-
NCT04932265Suspended